Please login to the form below
neurological disease
This page shows the latest neurological disease news and features for those working in and with pharma, biotech and healthcare.
AbbVie’s Parkinson’s disease therapy application rejected by FDA
We will continue to work closely with the FDA as part of our commitment to bringing this treatment option to people impacted by this disease as quickly as possible.". ... Parkinson's disease is a progressive and chronic neurological disorder resulting
Latest news
-
Sanofi reports positive new data for multiple sclerosis treatment tolebrutinib
MS is a disabling, unpredictable neurological disease in which the immune system attacks the protective myelin sheath that covers the nerves and disrupts communication between the brain and the rest of ... There is no cure for MS, with treatments
-
NICE publishes final draft guidance recommending three COVID-19 treatments
The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending three COVID-19 treatments for those at the highest risk of developing severe disease. ... This includes those who are immunosuppressed, or who
-
Tiziana’s foralumab shows continued clinical improvement in secondary progressive MS
MS is a disabling, unpredictable disease in which the immune system attacks the protective myelin sheath that covers the nerves and disrupts communication between the brain and the rest of the
-
Roche enters into second collaboration with Jnana to address complex drug targets
for the treatment of challenging-to-drug cancer, immune-mediated and neurological diseases. ... The collaboration will see Jnana conduct discovery and preclinical activities against multiple cancer, immune-mediated and neurological disease targets, with
-
Biogen and Denali dose first patients with LRRK2 inhibitor in Parkinson’s disease study
Disease Rating Scale (MDS-UPDRS) over the treatment period of up to 180 weeks. ... PD is the fastest growing neurological condition worldwide, with 145, 000 people in the UK living with the disease.
More from news
Approximately 7 fully matching, plus 41 partially matching documents found.
Latest Intelligence
-
A relentless commitment to neuroscience
The outlook can be sobering and, sadly, people living with chronic neurological illnesses including chronic migraine, Parkinson’s disease and psychiatric disorders continue to face stigma. ... We work tirelessly across all stages of neuroscience
-
How digital tools can support HCPs during and after the COVID-19 pandemic
Heart disease, cancer and neurological conditions have certainly not disappeared, health authorities continue to approve new treatments and indications and issue new guidelines, and patients still need help, which means HCPs
-
Can protein degraders unlock ‘undruggable’ drug targets?
Now, interest is growing in a largely-untapped approach to targeting disease-associated proteins, particularly those that for many years have been considered ‘undruggable’. ... C4 also has a collaboration in place with Biogen focusing on neurological
-
Pfizer and IBM's tech-enabled 'Parkinson’s house'
But this elegant home, surrounded by manicured lawns, is wired to beat the scourge of Parkinson’s disease. ... Even the mechanics of how someone gets up and down from a chair or bed can be calibrated and shaped into a personal disease signature.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest appointments
-
Ex Sanofi boss joins Boston start-up
Among the 12 companies in PureTech's pipeline are Akili Interactive Labs, which is a collaboration between game designers and neuroscientists to spot signs of the onset of Alzheimer's ... and other neurological conditions.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Are we ready for an Alzheimer's disease modifying treatment
As with many neurological diseases, Alzheimer’s disease is present long before the symptoms begin to show in a notable way. ... is considered the most feared disease of people over the age of 60.
-
My MS journey: one patient's search for innovation
It’s so important to go to a neurological hospital or a hospital that has a neurological department, which is taking the disease seriously.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Ketchum appoints Conor Nash as global chief financial officer and chief operating officer
PMHub
JPA Health
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
